Cargando…

CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway

Previous studies by our group have shown that low intra-prostatic dihydrotestosterone (DHT) induced BPH epithelial cells (BECs) to recruit CD8+ T cells. However, the influence of the recruited CD8+ T cells on BECs under a low androgen level is still unknown. Here, we found CD8+ T cells have the capa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yang, Hu, Shuai, Liu, Jie, Cui, Yun, Fan, Yu, Lv, Tianjing, Liu, Libo, Li, Jun, He, Qun, Han, Wenke, Yu, Wei, Sun, Yin, Jin, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316951/ https://www.ncbi.nlm.nih.gov/pubmed/28216616 http://dx.doi.org/10.1038/srep42893

Ejemplares similares

Activation of cGMP/PKG/p65 signaling associated with PDE5‐Is downregulates CCL5 secretion by CD8 (+) T cells in benign prostatic hyperplasia
por: Jin, Song, et al.
Publicado: (2019)

M2 macrophage-mediated interleukin-4 signalling induces myofibroblast phenotype during the progression of benign prostatic hyperplasia
por: Sheng, Jindong, et al.
Publicado: (2018)

Low Intraprostatic DHT Promotes the Infiltration of CD8+ T Cells in BPH Tissues via Modulation of CCL5 Secretion
por: Fan, Yu, et al.
Publicado: (2014)

Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
por: Park, Woo Yong, et al.
Publicado: (2022)

Roles of autophagy in androgen-induced benign prostatic hyperplasia in castrated rats
por: Liu, Rong-Fu, et al.
Publicado: (2018)

Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling
por: Xiang, Peng, et al.
Publicado: (2019)

Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia
por: Tong, Yu, et al.
Publicado: (2020)

The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia
por: Shi, Aiping, et al.
Publicado: (2015)

Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis
por: Yang, Yang, et al.
Publicado: (2022)

MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)

Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging
por: Cao, Dehong, et al.
Publicado: (2022)

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
por: Hata, Junya, et al.
Publicado: (2023)

Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia
por: Filipovski, Vanja, et al.
Publicado: (2017)

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features
por: Wang, Lu, et al.
Publicado: (2016)

Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia
por: Yang, Minggen, et al.
Publicado: (2021)

Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis
por: Jin, Bo-Ram, et al.
Publicado: (2020)

Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea
por: Lee, Chung Lyul, et al.
Publicado: (2016)

Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats
por: Hwangbo, Hyun, et al.
Publicado: (2018)

Possible mechanism of benign prostatic hyperplasia induced by androgen–estrogen ratios in castrated rats
por: Xiang-Yun, Liu, et al.
Publicado: (2010)

Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer
por: Hillebrand, Ana Caroline, et al.
Publicado: (2018)

Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
por: Agamia, Naglaa F., et al.
Publicado: (2016)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
por: Vickman, Renee E., et al.
Publicado: (2020)

Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals
por: Luo, Jie, et al.
Publicado: (2015)

Neferine attenuates development of testosterone-induced benign prostatic hyperplasia in mice by regulating androgen and TGF-β/Smad signaling pathways
por: Liu, Chi-Ming, et al.
Publicado: (2023)

The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia
por: Liu, Jiang, et al.
Publicado: (2023)

Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model
por: Lee, Gyuok, et al.
Publicado: (2017)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
por: Kim, Eric H., et al.
Publicado: (2018)

Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia
por: Jin, Bo-Ram, et al.
Publicado: (2018)

CD5-negative Blastoid Variant Mantle Cell Lymphoma with Complex CCND1/IGH and MYC Aberrations
por: Seok, Yoonmi, et al.
Publicado: (2012)

STAT4, a potential predictor of prognosis, promotes CD8 T‑cell infiltration in ovarian serous carcinoma by inducing CCL5 secretion
por: Wang, Wei, et al.
Publicado: (2023)

CCL5 Suppresses Klotho Expression via p-STAT3/DNA Methyltransferase1-Mediated Promoter Hypermethylation
por: Liu, QiFeng, et al.
Publicado: (2022)

Mixture of Corni Fructus and Schisandrae Fructus improves testosterone-induced benign prostatic hyperplasia through regulating 5α-reductase 2 and androgen receptor
por: Hwangbo, Hyun, et al.
Publicado: (2023)

Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer
por: Zhang, Li, et al.
Publicado: (2016)

Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8 chemokine expression
por: Hintzen, C, et al.
Publicado: (2009)

CCL5 and CCR5 Interaction Promotes Cell Motility in Human Osteosarcoma
por: Wang, Shih-Wei, et al.
Publicado: (2012)

Anti-CCL22 increases regulatory T cells in CD4(+) T cells of rheumatoid arthritis patients via STAT5 pathway
por: Wang, Ling, et al.
Publicado: (2020)

Infiltrating mast cells enhance benign prostatic hyperplasia through IL-6/STAT3/Cyclin D1 signals
por: Ou, Zhenyu, et al.
Publicado: (2017)

Exploring the effects and mechanism of peony pollen in treating benign prostatic hyperplasia
por: Mu, Jun, et al.
Publicado: (2023)

The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
por: Park, So-Yeon, et al.
Publicado: (2019)

Nursing Research on Benign Prostatic Hyperplasia Based on Continuous Nursing Care
por: Li, Shasha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ta7unrro9vlairuftk94vh7np3